What is the recommended acute treatment for a patient with ST‑elevation myocardial infarction, including reperfusion strategy, antiplatelet and anticoagulant therapy, high‑intensity statin, supplemental oxygen, nitroglycerin, beta‑blocker, morphine, ACE inhibitor, and post‑procedure management?

Treatment for STEMI

Immediate Reperfusion Strategy

Primary percutaneous coronary intervention (PCI) must be performed within 90-120 minutes of first medical contact and is the definitive reperfusion strategy for all STEMI patients with symptoms <12 hours duration and persistent ST-segment elevation. 1, 2

When Primary PCI is Available (≤120 minutes)

• Transfer the patient directly to the catheterization laboratory, bypassing the emergency department entirely (Class I, Level B recommendation). 1, 2
• Obtain a 12-lead ECG within 10 minutes of first medical contact to confirm ST-segment elevation and activate the catheterization laboratory immediately. 1, 2
• Place the patient on continuous cardiac monitoring with defibrillator capacity immediately available. 1
• The target door-to-balloon time is ≤60 minutes for patients presenting directly to a PCI-capable hospital, or ≤90 minutes for patients requiring transfer. 1

When Primary PCI Cannot Be Achieved Within 120 Minutes

Administer fibrinolytic therapy immediately, preferably in the pre-hospital setting (e.g., ambulance), within 30 minutes of STEMI diagnosis (Class I, Level A recommendation). 1, 2

• Use a fibrin-specific agent: tenecteplase, alteplase, or reteplase (Class I, Level B recommendation). 1, 2, 3
• Begin immediate transfer to a PCI-capable center during or immediately after the fibrinolytic infusion—do not wait to assess reperfusion success (Class I, Level A recommendation). 2
• All fibrinolysis patients require routine angiography and PCI of the infarct-related artery 2-24 hours after lysis if reperfusion is successful (Class I, Level A recommendation). 1, 2, 3

---

Immediate Pharmacotherapy

Antiplatelet Therapy

• Aspirin 150-325 mg orally (chewable preferred) or IV if unable to swallow should be given immediately to all patients without contraindications (Class I, Level B recommendation). 1, 2

For Primary PCI:

• Add a potent P2Y12 inhibitor before or at the time of PCI: prasugrel or ticagrelor are strongly preferred over clopidogrel (Class I, Level A recommendation). 1, 2
• Continue dual antiplatelet therapy (aspirin + ticagrelor/prasugrel) for 12 months unless excessive bleeding risk exists (Class I, Level A recommendation). 1, 2

For Fibrinolytic Therapy:

• Add clopidogrel (not prasugrel or ticagrelor initially): 300 mg loading dose if age <75 years, or 75 mg if age ≥75 years (Class I, Level A recommendation). 1, 2, 3
• Switch to ticagrelor or prasugrel 48 hours after fibrinolysis following successful PCI (Class I, Level B recommendation). 2

Anticoagulation Therapy

For Primary PCI:

• Use unfractionated heparin (UFH) as a weight-adjusted IV bolus (60 U/kg, max 4000 U) followed by infusion (12 U/kg/h, max 1000 U/h) targeting aPTT 1.5-2.0 × control (Class I, Level B recommendation). 1, 2
• Fondaparinux is contraindicated for primary PCI (Class III, Level B recommendation). 1, 2

For Fibrinolytic Therapy:

• Enoxaparin IV followed by subcutaneous is preferred over UFH (Class I, Level A recommendation): 30 mg IV bolus, then 1 mg/kg SC every 12 hours (adjust for age ≥75 years or CrCl <30 mL/min). 1, 2
• UFH is an acceptable alternative: weight-adjusted IV bolus followed by infusion (Class I, Level B recommendation). 1, 2
• Continue anticoagulation until revascularization or up to 8 days of hospital stay, whichever occurs first. 1, 2, 3

---

Post-Fibrinolysis Management: Rescue vs. Routine PCI

Assess Reperfusion Success at 60-90 Minutes

Monitor ST-segment resolution 60-90 minutes after fibrinolysis to determine the next step (Class I, Level A recommendation). 1, 2

Rescue PCI (Immediate Catheterization Laboratory)

Perform rescue PCI immediately without delay if any of the following occur (Class I, Level A recommendation): 1, 2

• <50% ST-segment resolution at 60-90 minutes (failed fibrinolysis). 1, 2, 3
• Hemodynamic instability or cardiogenic shock. 1, 2
• Sustained ventricular arrhythmias (electrical instability). 1, 2
• Recurrent chest pain with ST-segment re-elevation (re-occlusion). 1, 2

Routine Early PCI (2-24 Hours Post-Fibrinolysis)

• If fibrinolysis is successful (>50% ST-segment resolution, chest pain relief, reperfusion arrhythmias), perform angiography and PCI of the infarct-related artery 2-24 hours after lysis (Class I, Level A recommendation). 1, 2, 3
• This pharmacoinvasive strategy reduces reinfarction and recurrent ischemia compared with delayed PCI. 2, 4

---

Additional Acute Therapies

Pain Management

• Morphine sulfate may be used for pain control and anxiety reduction, particularly when nitrates are contraindicated (e.g., patients on phosphodiesterase-5 inhibitors). 5, 6
• Nitroglycerin (sublingual or IV) can be used for ongoing chest pain unless contraindicated (e.g., right ventricular infarction, hypotension, or recent phosphodiesterase-5 inhibitor use within 48 hours for tadalafil). 5

Oxygen Therapy

• Routine supplemental oxygen is NOT recommended in patients with SaO₂ ≥90% (Class III, Level B recommendation). 1, 2

Beta-Blockers

• Oral beta-blockers should be initiated within 24 hours in hemodynamically stable patients without contraindications (e.g., heart failure, bradycardia, hypotension). 6

ACE Inhibitors

• ACE inhibitors should be started within 24 hours in patients with anterior infarction, heart failure, or left ventricular ejection fraction <40%, unless contraindicated. 6

High-Intensity Statin Therapy

• Initiate or continue high-intensity statin therapy (e.g., atorvastatin 80 mg or rosuvastatin 40 mg daily) for all STEMI patients regardless of baseline cholesterol levels. 2, 5, 6

Proton Pump Inhibitor

• Add a proton pump inhibitor in patients at high gastrointestinal bleeding risk who are on dual antiplatelet therapy (Class I, Level B recommendation). 2

---

Post-Procedure In-Hospital Management

Echocardiography

• Perform routine transthoracic echocardiography during hospitalization to assess left and right ventricular function, detect mechanical complications (e.g., ventricular septal defect, papillary muscle rupture), and exclude left ventricular thrombus (Class I, Level B recommendation). 2, 5

Cardiac Rehabilitation

• Enroll all STEMI patients in a cardiac rehabilitation program before discharge (Class I, Level A recommendation). 2

Smoking Cessation

• Provide smoking cessation counseling with pharmacotherapy (nicotine replacement, varenicline, or bupropion) and follow-up support (Class I, Level A recommendation). 2

---

Critical Practices to Avoid

• Do NOT delay reperfusion therapy for administrative procedures such as insurance verification. 2
• Do NOT perform routine PCI of an occluded infarct-related artery >48 hours after symptom onset in asymptomatic, stable patients (Class III, Level A recommendation). 1, 2, 3
• Do NOT wait to assess reperfusion before transferring fibrinolysis patients—all require immediate transfer regardless of apparent success. 2
• Do NOT repeat fibrinolysis if the first dose fails—rescue PCI is the only option for failed lysis. 2
• Do NOT use fondaparinux as anticoagulant for primary PCI. 1, 2
• Do NOT administer nitrates to patients who have taken phosphodiesterase-5 inhibitors within 48 hours (for tadalafil) due to risk of severe, potentially fatal hypotension. 5, 3